참고문헌
- The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986 https://doi.org/10.1056/NEJM199309303291401
- Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z. H., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A. and Vlassara, H. N. (1993) Advanced glycosylation end products in patients with diabetic nephropathy. N. Eng. J. Med. 325, 836-842
- Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A. and Itoh, M. (1998) Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta 1425, 577-586 https://doi.org/10.1016/S0304-4165(98)00111-1
- Larkins, R. G. and Dunlop, M. E. (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35, 499-504 https://doi.org/10.1007/BF00400475
- Bucala, R. and Vlassara, H. (1995) Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis. 26, 875-888 https://doi.org/10.1016/0272-6386(95)90051-9
- Kalousova, M., Zima, T., Tesar, V., Stipek, S. and Sulkova, S. (2004) Advanced glycation end products in clinical nephrology. Kidney Blood Press Res. 27, 18-28 https://doi.org/10.1159/000075533
- Beyer-Mears, A. and Cruz, E. (1985) Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes 34, 15-21 https://doi.org/10.2337/diabetes.34.1.15
- Forbes, J. M., Cooper, M. E., Oldfield, M. D. and Thomas, M. C. (2003) Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14, S254-S258 https://doi.org/10.1097/01.ASN.0000077413.41276.17
- Yabe-Nishimura, C. (1998) Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50, 21-33
- Kim, J. S., Kim, H. and Ko, J. H. (2002) Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the formation of advanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Kor. J. Pharmacogn. 33, 308-311
- Bae, K., Medicinal Plants of Korea, Kyo-Hak Publishing Co., Seoul, 2000, p 92
- Li, Y. P., Takamiyagi, A., Ramzi, S. T. and Nonaka, S. (2000) Inhibitory effect of Rumex japonicus Houtt on the porphyrin photooxidative reaction. J. Dermatology, 27, 761-768 https://doi.org/10.1111/j.1346-8138.2000.tb02278.x
- Kim, D. K., Choi, S. U., Ryu, S. Y., Lee, K. R. and Zee, O. P. (1998) Cytotoxic constituents of Rumex japonicus. Yakhak Hoeji 42, 233-237
- Nishina, A., Kubota, K. and Osawa, T. (1993) Antimicrobial components, trachrysone and 2-methoxystypandrone, in Rumex japonicus Houtt. J. Agric. Food Chem., 41, 1772-1775 https://doi.org/10.1021/jf00034a047
- Aritomi, M., Kiyota, I. and Mazaki, T. (1965) Flavonoid constituents in leaves of Rumex acetosa and R. japonicus, Chem. Pharm. Bull. 13, 1470-1471 https://doi.org/10.1248/cpb.13.1470
- Zee, O. P., Kim, D. K., Kwon, H. C. and Lee, K. R. (1998) A new epoxynaphthoquinol from Rumex japonicus, Arch.Pharm. Res. 21, 485-486 https://doi.org/10.1007/BF02974649
- Hwang, S. W., Ha, T. J., Lee, J. R., Lee, J., Nam, S. H., Park, K. H. and Yang, M. S. (2004) Isolation of anthraquinone derivatives from the root of Rumex japonicus H. J. Korean Soc. Appl. Biol. Chem. 47, 274-278
- Jang, D. S., Kim, J. M., Kim, J. H. and Kim, J. S. (2005) 24-nor-ursane type triterpenoids from the stems of Rumex japonicus. Chem. Pharm. Bull. 53, 1594-1596 https://doi.org/10.1248/cpb.53.1594
- Vinson, J. A. and Howard III, T. B. (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7, 659-663 https://doi.org/10.1016/S0955-2863(96)00128-3
- Kim, H. Y. and Oh, J. H. (1999) Screening of Korean forest plants for rat lens aldose reductase inhibition. Biosci. Biotechnol. Biochem. 63, 184-188 https://doi.org/10.1271/bbb.63.184
- Matsuda, H., Morikawa, T., Toguchida, I. and Yoshikawa, M. (2002) Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 50, 788-795 https://doi.org/10.1248/cpb.50.788
- Park, W. Y. (1996) Phenolic compounds from Acer ginnala Maxim. Kor. J. Pharmacog. 27, 212-218
- Matsuda, H., Wang, T., Managi, H. and Yoshikawa, M.(2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11, 5317-5323 https://doi.org/10.1016/j.bmc.2003.09.045